Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibody
Chao Wang(Shaanxi Provincial People's Hospital), Bohua Li(Sichuan University), Xiaojie Yu(Jiangsu University), Huafeng Wei(Ministry of Education of the People's Republic of China), Cuihua Lu(Nantong University), Han Chen(Peking University), Yang� Yang(Shanghai Institute of Pharmaceutical Industry), Yajun Zhang(Tianjin Medical University Cancer Institute and Hospital), Lingfei Wang(Broad Institute), Yanping Sun(Heilongjiang University of Chinese Medicine), Yanchun Meng(Fudan University Shanghai Cancer Center), Huajing Wang(Shanghai University of Medicine and Health Sciences), Jian Zhao(Second Military Medical University), Jie Gao(Shanghai University)
Cited by 21
Related Papers
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
|Nature Cell Biology|2021|537
Black Carbon Emissions in China from 1949 to 2050
|Environmental Science & Technology|2012|313
Trend in Global Black Carbon Emissions from 1960 to 2007
|Environmental Science & Technology|2014|183
ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1
|Nature Cell Biology|2014|152